Results 71 to 80 of about 136,597 (121)

Discovery and optimization of marstacimab, a human monoclonal antibody targeting tissue factor pathway inhibitor for the treatment of hemophilia A and B. [PDF]

MAbs
Jin M, Hett S, Jasuja R, Rakhe S, Narula J, Tam A, Apgar JR, Juo ZS, Mosyak L, Holsti M, Joyce A, Hurst S, Webster R, Lin L, Stahl M, Pittman DD, Bloom L.   +16 more
europepmc   +1 more source

Antibody display technologies from phages to cells: translational bottlenecks and AI-enabled opportunities. [PDF]

Front Bioeng Biotechnol
Sahu A, Das P, Das R, Bhattacharya I, Bhattacharya T, Mohan U, Sreedhar R, Arumugam S.   +7 more
europepmc   +1 more source

Bispecific antibodies targeting herpes simplex virus glycoproteins B and D. [PDF]

Front Immunol
Atanasiu D, Saw WT, Cairns TM, Friedman HM, Cohen GH.   +4 more
europepmc   +1 more source

Identification of <i>Fasciola hepatica</i> gut-associated glycoproteins as potential vaccine candidates by lectin-affinity chromatography, flukicidal monoclonal antibodies, and affinity-enrichment mass spectrometry. [PDF]

Front Parasitol
Rechsteiner SG, Hasler S, Gehrig P, Deplazes P, Eichenberger RM.   +4 more
europepmc   +1 more source

Advanced 3D cancer models for analyzing tumor-immune cell interaction and therapeutic response. [PDF]

Mol Cancer
Jeevanandan SP, Reidy E, Clegg J, Curvello R, Ryan AE, Loessner D.   +5 more
europepmc   +1 more source

A novel TM4SF4-targeting therapeutic antibody candidate with antitumor activity by blocking IGF1R and CD44 signaling and downregulating PD-L1 and B7-H4. [PDF]

Theranostics
Kim RK, Heo CK, Choi MJ, Kahm YJ, Kim MK, Lee M, Lee JY, Park H, Jung U, Shin BC, Kim BJ, Kim SC, Cho EW, Ryu CJ, Kim IG.   +14 more
europepmc   +1 more source

B Cell Subsets and Atherosclerosis: Updates and Emerging Concepts. [PDF]

Immunol Rev
Lems S, Mazzei MG, Foks AC, McNamara CA.
europepmc   +1 more source

Progress in enterovirus D68-neutralizing antibodies and vaccines. [PDF]

J Virol
Wang L, Shen J.
europepmc   +1 more source

Oncofertility in the Age of HER2 Blockade, Immunotherapy, PARP inhibitors, CDK4/6 inhibitors and Endocrine Treatment: Unanswered Questions in Breast Cancer. [PDF]

Curr Treat Options Oncol
Weiner-Gorzel K, McSorley L, Walshe JM.
europepmc   +1 more source

Targeting oncogenic TβRI signaling inhibits androgen-independent prostate cancer growth and metastasis. [PDF]

Signal Transduct Target Ther
Flodbring Larsson P, Schmidt A, Mu Y, Zang G, Song J, Gajavilli V, Tao J, Rakhimova O, Ericsson M, Aripaka K, Halin Bergström S, Yuan W, Bogdan D, Zhang AH, Welti J, Bergh A, de Bono J, Heldin CH, Landström M.   +18 more
europepmc   +1 more source